Skip to content

DR. SOFIE DE BLAUWE

Active Private limited companyfounded 2014active for 11 yearsKleine Molenstraat 5 A, 8380 BrugesKBO/BCE: BE 0505.829.066

Lifetime

11 annual accounts with figures on one time axis
peak of €260,077 in 2025
€260,077▲ 24.1%
peak of €180,359 in 2025
€180,359▲ 18.5%
peak of €493,940 in 2022
€18,600▼ 81.6%
€263,039▼ 32.7%
Board2 names since 2014
2 directors and 1 other
Documentsfilings and deeds
04-06-202657 days before the deadline
2025micro format
Gross margin from €209,622 to €260,077Dividend €262,602Equity from €100,843 to €18,600Debts from €390,959 to €263,039Cash from €436,334 to €253,021

Key points

from the 2025 annual accounts

Equity

€18,600 from €493,940 in 2022

Equity fell by 96% in 3 years.

Debts

€263,039 93% of the balance sheet
Suppliers 0%Taxes and wages 1%Other 99%

Of this, €259,987 falls due within a year.

Position in the sector

6.6%

Lower solvency than 88% of companies in human health. Sector median 63.0% · 21,347 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,325 companies had the same profile as DR. SOFIE DE BLAUWE has now. Each dot stands for 4 companies, two years later.

95.2%
were still trading
3.2%
stopped another way
1.4%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,325 companies, not a prediction for DR. SOFIE DE BLAUWE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director, since 25-10-2023
  • 100 sharesdeed of 10-12-2014
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0505829066
changes role from manager to director Director discharge: · General meeting of 25-10-2023 · Gazette deed
Incorporation Founding capital of €18,600, 100 shares, €12,500 paid up · Founded by · appointed as manager · published on 10-12-2014 · Gazette deed
First establishment Kleine Molenstraat 5 A, Bruges
All 21 events

Comparable companies

same main activity, similar in size and age
Company
DR. SOFIE DE BLAUWE Bruges €281,639 €260,077 6.6% -
CABINET MEDICAL QUATTROCCHI Boussu €276,732 €246,359 22.6% -
Dokter Goossens Kristof Beerse €245,204 €248,655 82.1% -
DR. LEEN DE MAEYER Malle €295,189 €290,348 42.1% -
Dr. De Vooght-Dr. Delahaye Sint-Truiden €258,175 €282,303 92.7% -
Anadomus Waregem €238,191 €234,459 7.9% -
Dr. Tijs Demeyere Moorslede €372,903 €297,275 29.3% -

These companies have the same main activity as DR. SOFIE DE BLAUWE: general medical practice (NACE 86210). They are comparable in size and age: total assets between €238,000 and €373,000, founded between 2014 and 2017.

Official details

Source: KBO
Status
Active since 26-11-2014Normal situation
Activity
General medical practiceNACE 86210and 2 others
Establishment unit
2.239.101.1818380 Bruges, since 26-11-2014
Financial year end
31 December
Peppol
Reachable since 27-09-2024
Company details

Annual accounts 2025

≈ €400,000estimated
€281,639▼ 42.7%
Filing
Filed on 04-06-2026, 57 days before the end of the filing period
Financials

Insights on DR. SOFIE DE BLAUWE

DR. SOFIE DE BLAUWE files the micro format. That format states no turnover. The gross margin rose from €86,964 in 2015 to €260,077 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. SOFIE DE BLAUWE

What is the company number of DR. SOFIE DE BLAUWE?
The company number of DR. SOFIE DE BLAUWE is 0505.829.066. The VAT number is the same number with BE in front: BE 0505.829.066.
Where is DR. SOFIE DE BLAUWE based?
The registered office is at Kleine Molenstraat 5 A, 8380 Bruges.Company details
What does DR. SOFIE DE BLAUWE do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. SOFIE DE BLAUWE?
DR. SOFIE DE BLAUWE is a private limited company (BV).
When was DR. SOFIE DE BLAUWE founded?
DR. SOFIE DE BLAUWE was founded on 26-11-2014.
Is DR. SOFIE DE BLAUWE still active?
Yes, DR. SOFIE DE BLAUWE is an active enterprise in the KBO register.
What is the turnover of DR. SOFIE DE BLAUWE?
The turnover in financial year 2025 is ≈ €400,000. This figure is estimated from the gross margin of €260,077 and 38 comparable companies (NACE 862). It probably lies between €350,000 and €500,000.Financials
Is DR. SOFIE DE BLAUWE profitable?
In financial year 2025, DR. SOFIE DE BLAUWE made a profit of €180,359.
Where can I find the annual accounts of DR. SOFIE DE BLAUWE?
DR. SOFIE DE BLAUWE filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. SOFIE DE BLAUWE due?
DR. SOFIE DE BLAUWE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.